Proto Script Pharmaceutical

Proto Script Pharmaceutical Enterprise Value

The Enterprise Value (EV) of Proto Script Pharmaceutical (PSCR) as of Oct 9, 2026 is 5,690.44 USD. In the previous year, Enterprise Value (EV) was 5,690.44 USD — a change of 0.00% (lower).

Enterprise Value

5,690.44USD

YoY

0.00%

Last updated:

Enterprise Value (EV) of Proto Script Pharmaceutical is 2022 5,690.44 USD. Enterprise Value (EV) of Proto Script Pharmaceutical was 2021 5,690.44 USD. It decreases by 0.00% lower compared to the previous year.

The Proto Script Pharmaceutical Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2014
5,690.44 USD
Jan 1, 2015
32,759.44 USD
Jan 1, 2016
87,530.44 USD
Jan 1, 2019
5,690.44 USD
Jan 1, 2020
5,690.44 USD
Jan 1, 2021
5,690.44 USD
Jan 1, 2022
5,690.44 USD
The Proto Script Pharmaceutical Enterprise Value history
YEAREnterprise ValueYoY
5,690.44USD0.00%
5,690.44USD0.00%
5,690.44USD0.00%
5,690.44USD-93.50%
87,530.44USD+167.19%
32,759.44USD+475.69%
5,690.44USD—
Access this data via the Eulerpool API

Proto Script Pharmaceutical Stock analysis

What does Proto Script Pharmaceutical do? Proto Script Pharmaceutical Corp is an American biotechnology company specializing in the development and manufacture of innovative, high-quality drugs. The company is focused on researching new breakthrough technologies in drug manufacturing to find potential cures and treat diseases. Their business model is based on producing medications that are highly effective and of high quality while also being cost-effective and patient-friendly. They collaborate closely with biotechnology companies and academic institutions to acquire the best technologies and develop effective and innovative drugs. They have products in the areas of neurology, endocrine health, and oncology. They have also entered into partnerships with other companies to expand and further develop their products. Overall, Proto Script Pharmaceutical Corp is a groundbreaking company in the biotechnology field with decades of experience in drug development and a commitment to improving the lives of millions of people worldwide. Proto Script Pharmaceutical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Proto Script Pharmaceutical stock

Enterprise Value (EV) of Proto Script Pharmaceutical is 5,690.44 USD in 2022.

Enterprise Value (EV) of Proto Script Pharmaceutical changed from 5,690.44 USD to 5,690.44 USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Proto Script Pharmaceutical since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Proto Script Pharmaceutical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Proto Script Pharmaceutical

All Key Metrics — Proto Script Pharmaceutical